XAIR 250117 2.50C (XAIR250117C2500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

XAIR250117C2500

Watchlist

0.05
0.000.00%

15min DelayTrading Dec 26 09:33 ET

0.05High0.05Low

Intraday

5D
Daily

News

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for Its INO Products
GlobeNewswireDec 9 11:00 ET
Express News | Beyond Cancer: Israeli Ministry of Health Approved Use of Low Volume Uno in Phase 1B Clinical Trial of Lv Uno in Combination With Anti-Pd-1 Therapy
ReutersDec 3 17:29 ET
Express News | Advisory- Alert on Beyond Cancer's Clinical Trial Approval Was Incorrectly Tagged to Beyond Air and Is Being Withdrawn
ReutersDec 3 17:16 ET
Beyond Air Announces IMOH Approval of LV UNO Trial
TipRanksDec 3 16:11 ET
Beyond Cancer Secures Approval From Israeli Ministry Of Health For Phase 1b Trial Combining Low Volume Ultra-High Concentration Nitric Oxide With Anti-PD-1 Therapy In Solid Tumor Patients
BenzingaDec 3 16:09 ET
Express News | Beyond Air Receives Ce Mark in Europe for the Lungfit® Ph System
ReutersDec 2 07:34 ET

Comments

Trytosaveabit

Dec 3 16:36

Grrrr! They need to be more careful!

$Beyond Air (XAIR.US)$ Reuters· 17 mins ago
Advisory- Alert on Beyond Cancer's Clinical Trial Approval Was Incorrectly Tagged to Beyond Air and Is Being Withdrawn

This_Guy

Dec 3 15:05

$Beyond Air (XAIR.US)$
👀

Jaguar8

Dec 3 15:05

NEWS

$Beyond Air (XAIR.US)$
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
Tuesday, 3rd December at 4:05 pm
• The Phase 1b study will evaluate LV UNO in unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic solid tumor cancer patients that have progressed or have prolonged stable disease on single agent P...

Jaguar8

Dec 2 18:05

🔴WATCHLIST Tuesday 12/3. NFA. Don’t open position without momentum. Use charts+indicators+order book. NO FOMO.

Note: This seems to be a long list. The rationale is that I al focused on at least 20% gains and not just after bangers. My trading style is to compound those 10-15-20-30% earnings and roll all profit rather than waiting for runners everyday. If runners appear, then I’ll grab it as well. Each has his own style earning.
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...

Jaguar8

Dec 2 06:41

NEWS

$Beyond Air (XAIR.US)$
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
Monday, 2nd December at 7:30 am
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery
A $1 million milestone payment is triggered from Asia-Pacific partner, Getz Healthcare